Bleeding Disorder Treatment Market Size, Share | Report 2022,28

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Bleeding Disorder Treatment Market - By Disease Type
1.3.2 Bleeding Disorder Treatment Market - By Drug Class
1.3.3 Bleeding Disorder Treatment Market - By Distribution Channel
1.3.4 Bleeding Disorder Treatment Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. BLEEDING DISORDER TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. BLEEDING DISORDER TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. BLEEDING DISORDER TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. BLEEDING DISORDER TREATMENT - GLOBAL MARKET OVERVIEW
6.2. BLEEDING DISORDER TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. BLEEDING DISORDER TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE TYPE
7.1. OVERVIEW
7.2. DISEASE TYPE MARKET FORECASTS AND ANALYSIS
7.3. HEMOPHILIA A
7.3.1. Overview
7.3.2. Hemophilia A Market Forecast and Analysis
7.4. HEMOPHILIA B
7.4.1. Overview
7.4.2. Hemophilia B Market Forecast and Analysis
7.5. VON WILLEBRAND DISEASE
7.5.1. Overview
7.5.2. Von Willebrand Disease Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. BLEEDING DISORDER TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
8.1. OVERVIEW
8.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
8.3. PLASMA-DERIVED COAGULATION FACTOR CONCENTRATES
8.3.1. Overview
8.3.2. Plasma-derived Coagulation Factor Concentrates Market Forecast and Analysis
8.4. RECOMBINANT COAGULATION FACTOR CONCENTRATES
8.4.1. Overview
8.4.2. Recombinant Coagulation Factor Concentrates Market Forecast and Analysis
8.5. DESMOPRESSIN
8.5.1. Overview
8.5.2. Desmopressin Market Forecast and Analysis
8.6. ANTIFIBRINOLYTICS
8.6.1. Overview
8.6.2. Antifibrinolytics Market Forecast and Analysis
8.7. FIBRIN SEALANTS
8.7.1. Overview
8.7.2. Fibrin Sealants Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. BLEEDING DISORDER TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis

10. BLEEDING DISORDER TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Bleeding Disorder Treatment Market Overview
10.1.2 North America Bleeding Disorder Treatment Market Forecasts and Analysis
10.1.3 North America Bleeding Disorder Treatment Market Forecasts and Analysis - By Disease Type
10.1.4 North America Bleeding Disorder Treatment Market Forecasts and Analysis - By Drug Class
10.1.5 North America Bleeding Disorder Treatment Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Bleeding Disorder Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Bleeding Disorder Treatment Market
10.1.6.1.1 United States Bleeding Disorder Treatment Market by Disease Type
10.1.6.1.2 United States Bleeding Disorder Treatment Market by Drug Class
10.1.6.1.3 United States Bleeding Disorder Treatment Market by Distribution Channel
10.1.6.2 Canada Bleeding Disorder Treatment Market
10.1.6.2.1 Canada Bleeding Disorder Treatment Market by Disease Type
10.1.6.2.2 Canada Bleeding Disorder Treatment Market by Drug Class
10.1.6.2.3 Canada Bleeding Disorder Treatment Market by Distribution Channel
10.1.6.3 Mexico Bleeding Disorder Treatment Market
10.1.6.3.1 Mexico Bleeding Disorder Treatment Market by Disease Type
10.1.6.3.2 Mexico Bleeding Disorder Treatment Market by Drug Class
10.1.6.3.3 Mexico Bleeding Disorder Treatment Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Bleeding Disorder Treatment Market Overview
10.2.2 Europe Bleeding Disorder Treatment Market Forecasts and Analysis
10.2.3 Europe Bleeding Disorder Treatment Market Forecasts and Analysis - By Disease Type
10.2.4 Europe Bleeding Disorder Treatment Market Forecasts and Analysis - By Drug Class
10.2.5 Europe Bleeding Disorder Treatment Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Bleeding Disorder Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Bleeding Disorder Treatment Market
10.2.6.1.1 Germany Bleeding Disorder Treatment Market by Disease Type
10.2.6.1.2 Germany Bleeding Disorder Treatment Market by Drug Class
10.2.6.1.3 Germany Bleeding Disorder Treatment Market by Distribution Channel
10.2.6.2 France Bleeding Disorder Treatment Market
10.2.6.2.1 France Bleeding Disorder Treatment Market by Disease Type
10.2.6.2.2 France Bleeding Disorder Treatment Market by Drug Class
10.2.6.2.3 France Bleeding Disorder Treatment Market by Distribution Channel
10.2.6.3 Italy Bleeding Disorder Treatment Market
10.2.6.3.1 Italy Bleeding Disorder Treatment Market by Disease Type
10.2.6.3.2 Italy Bleeding Disorder Treatment Market by Drug Class
10.2.6.3.3 Italy Bleeding Disorder Treatment Market by Distribution Channel
10.2.6.4 Spain Bleeding Disorder Treatment Market
10.2.6.4.1 Spain Bleeding Disorder Treatment Market by Disease Type
10.2.6.4.2 Spain Bleeding Disorder Treatment Market by Drug Class
10.2.6.4.3 Spain Bleeding Disorder Treatment Market by Distribution Channel
10.2.6.5 United Kingdom Bleeding Disorder Treatment Market
10.2.6.5.1 United Kingdom Bleeding Disorder Treatment Market by Disease Type
10.2.6.5.2 United Kingdom Bleeding Disorder Treatment Market by Drug Class
10.2.6.5.3 United Kingdom Bleeding Disorder Treatment Market by Distribution Channel
10.2.6.6 Rest of Europe Bleeding Disorder Treatment Market
10.2.6.6.1 Rest of Europe Bleeding Disorder Treatment Market by Disease Type
10.2.6.6.2 Rest of Europe Bleeding Disorder Treatment Market by Drug Class
10.2.6.6.3 Rest of Europe Bleeding Disorder Treatment Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Bleeding Disorder Treatment Market Overview
10.3.2 Asia-Pacific Bleeding Disorder Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Bleeding Disorder Treatment Market Forecasts and Analysis - By Disease Type
10.3.4 Asia-Pacific Bleeding Disorder Treatment Market Forecasts and Analysis - By Drug Class
10.3.5 Asia-Pacific Bleeding Disorder Treatment Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Bleeding Disorder Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Bleeding Disorder Treatment Market
10.3.6.1.1 Australia Bleeding Disorder Treatment Market by Disease Type
10.3.6.1.2 Australia Bleeding Disorder Treatment Market by Drug Class
10.3.6.1.3 Australia Bleeding Disorder Treatment Market by Distribution Channel
10.3.6.2 China Bleeding Disorder Treatment Market
10.3.6.2.1 China Bleeding Disorder Treatment Market by Disease Type
10.3.6.2.2 China Bleeding Disorder Treatment Market by Drug Class
10.3.6.2.3 China Bleeding Disorder Treatment Market by Distribution Channel
10.3.6.3 India Bleeding Disorder Treatment Market
10.3.6.3.1 India Bleeding Disorder Treatment Market by Disease Type
10.3.6.3.2 India Bleeding Disorder Treatment Market by Drug Class
10.3.6.3.3 India Bleeding Disorder Treatment Market by Distribution Channel
10.3.6.4 Japan Bleeding Disorder Treatment Market
10.3.6.4.1 Japan Bleeding Disorder Treatment Market by Disease Type
10.3.6.4.2 Japan Bleeding Disorder Treatment Market by Drug Class
10.3.6.4.3 Japan Bleeding Disorder Treatment Market by Distribution Channel
10.3.6.5 South Korea Bleeding Disorder Treatment Market
10.3.6.5.1 South Korea Bleeding Disorder Treatment Market by Disease Type
10.3.6.5.2 South Korea Bleeding Disorder Treatment Market by Drug Class
10.3.6.5.3 South Korea Bleeding Disorder Treatment Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Bleeding Disorder Treatment Market
10.3.6.6.1 Rest of Asia-Pacific Bleeding Disorder Treatment Market by Disease Type
10.3.6.6.2 Rest of Asia-Pacific Bleeding Disorder Treatment Market by Drug Class
10.3.6.6.3 Rest of Asia-Pacific Bleeding Disorder Treatment Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Bleeding Disorder Treatment Market Overview
10.4.2 Middle East and Africa Bleeding Disorder Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Bleeding Disorder Treatment Market Forecasts and Analysis - By Disease Type
10.4.4 Middle East and Africa Bleeding Disorder Treatment Market Forecasts and Analysis - By Drug Class
10.4.5 Middle East and Africa Bleeding Disorder Treatment Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Bleeding Disorder Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Bleeding Disorder Treatment Market
10.4.6.1.1 South Africa Bleeding Disorder Treatment Market by Disease Type
10.4.6.1.2 South Africa Bleeding Disorder Treatment Market by Drug Class
10.4.6.1.3 South Africa Bleeding Disorder Treatment Market by Distribution Channel
10.4.6.2 Saudi Arabia Bleeding Disorder Treatment Market
10.4.6.2.1 Saudi Arabia Bleeding Disorder Treatment Market by Disease Type
10.4.6.2.2 Saudi Arabia Bleeding Disorder Treatment Market by Drug Class
10.4.6.2.3 Saudi Arabia Bleeding Disorder Treatment Market by Distribution Channel
10.4.6.3 U.A.E Bleeding Disorder Treatment Market
10.4.6.3.1 U.A.E Bleeding Disorder Treatment Market by Disease Type
10.4.6.3.2 U.A.E Bleeding Disorder Treatment Market by Drug Class
10.4.6.3.3 U.A.E Bleeding Disorder Treatment Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Bleeding Disorder Treatment Market
10.4.6.4.1 Rest of Middle East and Africa Bleeding Disorder Treatment Market by Disease Type
10.4.6.4.2 Rest of Middle East and Africa Bleeding Disorder Treatment Market by Drug Class
10.4.6.4.3 Rest of Middle East and Africa Bleeding Disorder Treatment Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Bleeding Disorder Treatment Market Overview
10.5.2 South and Central America Bleeding Disorder Treatment Market Forecasts and Analysis
10.5.3 South and Central America Bleeding Disorder Treatment Market Forecasts and Analysis - By Disease Type
10.5.4 South and Central America Bleeding Disorder Treatment Market Forecasts and Analysis - By Drug Class
10.5.5 South and Central America Bleeding Disorder Treatment Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Bleeding Disorder Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Bleeding Disorder Treatment Market
10.5.6.1.1 Brazil Bleeding Disorder Treatment Market by Disease Type
10.5.6.1.2 Brazil Bleeding Disorder Treatment Market by Drug Class
10.5.6.1.3 Brazil Bleeding Disorder Treatment Market by Distribution Channel
10.5.6.2 Argentina Bleeding Disorder Treatment Market
10.5.6.2.1 Argentina Bleeding Disorder Treatment Market by Disease Type
10.5.6.2.2 Argentina Bleeding Disorder Treatment Market by Drug Class
10.5.6.2.3 Argentina Bleeding Disorder Treatment Market by Distribution Channel
10.5.6.3 Rest of South and Central America Bleeding Disorder Treatment Market
10.5.6.3.1 Rest of South and Central America Bleeding Disorder Treatment Market by Disease Type
10.5.6.3.2 Rest of South and Central America Bleeding Disorder Treatment Market by Drug Class
10.5.6.3.3 Rest of South and Central America Bleeding Disorder Treatment Market by Distribution Channel

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. BLEEDING DISORDER TREATMENT MARKET, KEY COMPANY PROFILES
12.1. ALNYLAM PHARMACEUTICALS, INC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. AMGEN, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. TAKEDA PHARMACEUTICALS U.S.A., INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BAYER AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GRIFOLS, S.A.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. OCTAPHARMA AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NOVO NORDISK A/S
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PFIZER, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SANOFI
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. CSL
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS